Analysts: GlaxoSmithKline PLC (GSK)

GSK on New York Consolidated

48.87USD
28 Aug 2014
Price Change (% chg)

$0.20 (+0.41%)
Prev Close
$48.67
Open
$48.93
Day's High
$48.98
Day's Low
$48.71
Volume
2,704,317
Avg. Vol
3,142,125
52-wk High
$56.73
52-wk Low
$46.01

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -- December 29 Aug 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 2 2
(2) OUTPERFORM 0 0 0 0
(3) HOLD 4 4 3 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.60 2.60 2.20 2.20

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 2 10,430.70 11,011.20 9,850.20 --
Quarter Ending Dec-14 2 11,342.00 11,855.60 10,828.40 --
Year Ending Dec-14 4 39,392.20 39,719.50 38,887.00 43,825.90
Year Ending Dec-15 4 41,400.20 43,628.90 39,361.50 44,934.60
Earnings (per share)
Year Ending Dec-14 4 3.24 3.47 3.11 3.78
Year Ending Dec-15 4 3.41 3.85 3.06 --
LT Growth Rate (%) 1 3.70 3.70 3.70 4.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-14 10,079.80 9,359.61 720.17 7.14
Quarter Ending Mar-14 9,846.03 9,317.58 528.45 5.37
Quarter Ending Dec-13 11,183.30 11,184.40 1.13 0.01
Quarter Ending Sep-13 10,808.80 9,765.00 1,043.82 9.66
Quarter Ending Jun-13 10,048.70 10,191.70 143.03 1.42
Earnings (per share)
Quarter Ending Dec-13 0.96 0.97 0.01 1.04
Quarter Ending Dec-12 0.72 1.04 0.32 44.22
Quarter Ending Jun-12 0.66 0.83 0.17 26.35
Quarter Ending Mar-12 0.69 0.85 0.16 23.49
Quarter Ending Dec-11 0.59 0.78 0.19 31.16

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 10,430.70 10,430.70 10,430.70 10,680.70 --
Quarter Ending Dec-14 11,342.00 11,342.00 11,342.00 11,518.80 --
Year Ending Dec-14 39,392.20 39,392.20 40,330.90 40,934.90 43,825.90
Year Ending Dec-15 41,400.20 41,400.20 42,551.60 43,641.70 44,934.60
Earnings (per share)
Year Ending Dec-14 3.24 3.24 3.34 3.48 3.78
Year Ending Dec-15 3.41 3.41 3.61 4.03 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-14 0 0 0 0
Quarter Ending Dec-14 0 0 0 0
Year Ending Dec-14 0 0 1 2
Year Ending Dec-15 0 0 1 2
Earnings
Year Ending Dec-14 0 0 0 2
Year Ending Dec-15 0 0 0 1

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks